So the utilisation rate in malaysia will decreased. Now they unable to do tis due to license problem. Vietnam and indonesia plant still suffering lose vietnam plant will breakeven in 2 years time
The company do not planned for any expansion other than in vietnam and indonesia plant. For Malaysia, although the utilised rate stood at 80percent, management think that this is not a problem as they can change a more efficient machine to increase the production of the medicine
3. Last quarter profit margin improvement mainly due to gst effect.As the gst coming, the sales to clinic have been increased. As the sales to clinic generated the most profit margin to the company, hence the profit margin also increased
4. As per management the company gain the most profit margin mainly from sales to clinic while the lowest profit margin from government contract as they need to compete with other company to able to bid the contract. Hence they will lower down the profit margin
6. Obe of the shareholeer asked why yspsah choose to go in indonesia market. The management answered that the company go into indonesia market due to the indonesia market have opened their market 4years ago. The shareholder continue to ask do the management have any forecast on the sales in indonesia. The management said the company invest in indonesia for "test water". They will continue invest in indonesia anout 4 million for next few years
7. One of the shareholder have asked that the interest income gains from cash and cash equivalent is lesser than finance cost. Hence the company have any planned to better planning on the cash flow. The management said actually the company does not have as many cash as shown in balance sheet. Only because the timing differences as that time the money collect from debtor and the money which spend for working capital did not used at the moment
9. The company did not planned to enter china market due to the sister company, yongshin china have been entered into china market for more than 20years.But they only able to get aingle digit of licenses. But the company have join ventures with other china company in china market
11. The other product such as cosmetic product only contribute less than 1percent to the company. One of the shareholder asked does the company have the intention to enter into cosmetic product. The management said the company are trying to enter the market but because of cosmetic product normally depends on branding. So the company unable to compete with others. The company is still in the learning progress for the particular industries
12. The management said that cost of material consist of 55percent consists of cost of material which 90percent imported from oversea. The next biggest cost is packaging cost. Electricity only consist 2percent of the cost of sales of the medicine
Ykloh: the problem now is from the audited report, the company only incurred only small portion of revenue from there. (In other coutries revenue) As shareholder we concern about whether the medicine can be sold.or not. Other than that from the reaction and respon from management i feel like they dont know and not very understand on this company.They might focus on the yong shin taiwan business more.
Wow, owe you a meal for these previous info! THANK YOU!
Since last qtr sales is partly due to pre- GST effect, means Q2 sales will drop back? Looks like indonesia plant is not going to make money anytime soon?
10. The company foresee a improvement in the sales to government project as the company started to supplier to government. << Is the surge in revenue in last two quarters also due to this?
I think abit from government project. Im not sure. Just that last quarter surged mainly due to increase in sales to clinic. I sold because because of the share price from 1.6 until 2.5 now. I didnt expect any huger profit improvement in the coming quarter. Maybe next quarter will improved but impossible to remain the same as current quarter
Just to remind you that according to management government project provided the lowest profit margin among all of the sales. So i dont tink is a good thing for the company
selling pressure consider low despite weak broad market. Once broad market is stabilized + good coming qtr result, there is high chance for YSPSAH to break into uncharted territory!
Hopeful it can gain momentum to move above 2.69... Where is our bank Analyst, Research House??? Yspsah didn't gain as much coverage as Pharmaniaga, CCMDBIO or even Hovid.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pingdan
1,549 posts
Posted by pingdan > 2015-06-29 12:47 | Report Abuse
So the utilisation rate in malaysia will decreased. Now they unable to do tis due to license problem. Vietnam and indonesia plant still suffering lose vietnam plant will breakeven in 2 years time